Published in Cell Mol Neurobiol on December 01, 2004
Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci (2008) 5.12
Excitation, inhibition, local oscillations, or large-scale loops: what causes the symptoms of schizophrenia? Curr Opin Neurobiol (2011) 1.35
Inhibition of NMDARs in the Nucleus Reticularis of the Thalamus Produces Delta Frequency Bursting. Front Neural Circuits (2009) 1.28
Angiotensin II AT1 receptor blockade ameliorates brain inflammation. Neuropsychopharmacology (2010) 1.21
A thalamo-hippocampal-ventral tegmental area loop may produce the positive feedback that underlies the psychotic break in schizophrenia. Biol Psychiatry (2010) 1.13
The reuniens and rhomboid nuclei: neuroanatomy, electrophysiological characteristics and behavioral implications. Prog Neurobiol (2013) 1.07
NMDAR antagonist action in thalamus imposes δ oscillations on the hippocampus. J Neurophysiol (2012) 0.98
PCP-based mice models of schizophrenia: differential behavioral, neurochemical and cellular effects of acute and subchronic treatments. Psychopharmacology (Berl) (2015) 0.76
Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses. Arch Gen Psychiatry (1994) 8.88
Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry (1991) 8.10
Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. Annu Rev Neurosci (1991) 5.06
Frontal-subcortical neuronal circuits and clinical neuropsychiatry: an update. J Psychosom Res (2002) 4.17
A unitary model of schizophrenia: Bleuler's "fragmented phrene" as schizencephaly. Arch Gen Psychiatry (1999) 2.93
Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs. Science (1989) 2.77
Glutamate receptor function in learning and memory. Behav Brain Res (2003) 2.72
Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology (1995) 2.53
Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system. Pharmacol Rev (1995) 1.81
Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia? Biol Psychiatry (1995) 1.71
NMDA receptor antagonists impair prefrontal cortex function as assessed via spatial delayed alternation performance in rats: modulation by dopamine. J Neurosci (1996) 1.58
Qualitative and quantitative comparison of the prefrontal cortex in rat and in primates, including humans. Prog Brain Res (1990) 1.49
Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity. Biol Psychiatry (1993) 1.41
Advances in schizophrenia. Nat Med (2001) 1.32
Psychosis: pathological activation of limbic thalamocortical circuits by psychomimetics and schizophrenia? Trends Neurosci (2001) 1.09
Ketamine impairs multiple cognitive domains in rhesus monkeys. Drug Alcohol Depend (2002) 1.05
Bilateral blockade of NMDA receptors in anterior thalamus by dizocilpine (MK-801) injures pyramidal neurons in rat retrosplenial cortex. Eur J Neurosci (2000) 0.99
Differential effects of MK-801 on brain-derived neurotrophic factor mRNA levels in different regions of the rat brain. Exp Neurol (1993) 0.95
The orbitofrontal cortex and its connections with the mediodorsal nucleus in rabbit, sheep and cat. Res Publ Assoc Res Nerv Ment Dis (1948) 0.93
Midline thalamic region: widespread excitatory input to the entorhinal cortex and amygdala. J Neurosci (2002) 0.92
Induction and suppression of immediate early genes in specific rat brain regions by the non-competitive N-methyl-D-aspartate receptor antagonist MK-801. Neuroscience (1993) 0.92
MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex. Ann Neurol (1991) 0.89
In vivo regulation of dopamine and noradrenaline release by alpha2A-adrenoceptors in the mouse prefrontal cortex. Eur J Neurosci (2002) 0.82
MK801 induces c-fos protein in thalamic and neocortical neurons of rat brain. Neurosci Lett (1990) 0.81
Distinct pattern of c-fos mRNA expression after systemic and intra-accumbens amphetamine and MK-801. Neuroscience (2002) 0.81
Induction of c-fos and CRF mRNA by MK-801 in the parvocellular paraventricular nucleus of the rat hypothalamus. Brain Res Mol Brain Res (1994) 0.79
Pathogenesis of schizophrenia: Part I. Symptomatology, cognitive characteristics and brain morphology. Psychiatry Clin Neurosci (2003) 0.78
"Targeting" schizophrenia in mice. Am J Med Genet (2001) 0.77
Connecting the "dots" of brain dysfunction in schizophrenia: what does the picture look like? Arch Gen Psychiatry (1999) 0.77
Regional effects of MK-801 on dopamine release: effects of competitive NMDA or 5-HT2A receptor blockade. J Pharmacol Exp Ther (1996) 0.77
Excitatory actions of NMDA receptor antagonists in rat entorhinal cortex and cultured entorhinal cortical neurons. Neuropsychopharmacology (1999) 0.76
Pathogenesis of schizophrenia: Part II. Temporo-frontal two-step hypothesis. Psychiatry Clin Neurosci (2003) 0.76
FOS expression in the brainstem and cerebellum following phencyclidine and MK801. J Neurosci Res (1996) 0.75
Dizocilpine (MK-801) elicits a tetrodotoxin-sensitive increase in extracellular release of dopamine in rat medial frontal cortex. Neurochem Int (1995) 0.75
The antidepressant fluoxetine restores plasticity in the adult visual cortex. Science (2008) 4.36
Brain-derived neurotrophic factor and antidepressant drugs have different but coordinated effects on neuronal turnover, proliferation, and survival in the adult dentate gyrus. J Neurosci (2005) 3.02
Activation of the TrkB neurotrophin receptor is induced by antidepressant drugs and is required for antidepressant-induced behavioral effects. J Neurosci (2003) 2.66
Amyloid beta-induced neuronal hyperexcitability triggers progressive epilepsy. J Neurosci (2009) 2.33
Fear erasure in mice requires synergy between antidepressant drugs and extinction training. Science (2011) 2.25
Neurocognitive aging: prior memories hinder new hippocampal encoding. Trends Neurosci (2006) 2.20
Age-associated alterations of hippocampal place cells are subregion specific. J Neurosci (2005) 1.82
Increased fMRI responses during encoding in mild cognitive impairment. Neurobiol Aging (2006) 1.74
Role of alpha-synuclein in presynaptic dopamine recruitment. J Neurosci (2004) 1.74
Pharmacologically diverse antidepressants rapidly activate brain-derived neurotrophic factor receptor TrkB and induce phospholipase-Cgamma signaling pathways in mouse brain. Neuropsychopharmacology (2007) 1.64
Visual presentation of novel objects and new spatial arrangements of objects differentially activates the medial temporal lobe subareas in humans. Eur J Neurosci (2004) 1.63
Epigenetic modifications induced by early enrichment are associated with changes in timing of induction of BDNF expression. Neurosci Lett (2011) 1.62
Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease. J Neurochem (2013) 1.51
Gender differences in the amount and deposition of amyloidbeta in APPswe and PS1 double transgenic mice. Neurobiol Dis (2003) 1.48
Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J Neurochem (2008) 1.36
Orexin loss in Huntington's disease. Hum Mol Genet (2004) 1.33
Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2009) 1.31
Flexible polyimide microelectrode array for in vivo recordings and current source density analysis. Biosens Bioelectron (2006) 1.28
Pyrrolidine dithiocarbamate activates Akt and improves spatial learning in APP/PS1 mice without affecting beta-amyloid burden. J Neurosci (2007) 1.28
Analysis and visualization of gene expression data using self-organizing maps. Neural Netw (2002) 1.22
Increased expression of the dyslexia candidate gene DCDC2 affects length and signaling of primary cilia in neurons. PLoS One (2011) 1.22
Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease. J Neuroinflammation (2010) 1.18
Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease. J Pharmacol Exp Ther (2004) 1.17
Transgenic mice overexpressing the full-length neurotrophin receptor trkB exhibit increased activation of the trkB-PLCgamma pathway, reduced anxiety, and facilitated learning. Mol Cell Neurosci (2004) 1.17
Longitudinal observation on CSF Abeta42 levels in young to middle-aged amyloid precursor protein/presenilin-1 doubly transgenic mice. Neurobiol Dis (2004) 1.17
Cognitive aging and the hippocampus: how old rats represent new environments. J Neurosci (2004) 1.17
Altered differentiation of neural stem cells in fragile X syndrome. Proc Natl Acad Sci U S A (2005) 1.16
Non-fibrillar beta-amyloid abates spike-timing-dependent synaptic potentiation at excitatory synapses in layer 2/3 of the neocortex by targeting postsynaptic AMPA receptors. Eur J Neurosci (2006) 1.15
Expression of interleukin-18 is increased in the brains of Alzheimer's disease patients. Neurobiol Aging (2007) 1.15
Locomotor activity and evoked dopamine release are reduced in mice overexpressing A30P-mutated human alpha-synuclein. Neurobiol Dis (2005) 1.15
Antipsychotic drug treatment induces differential gene expression in the rat cortex. J Neurochem (2002) 1.14
Cortical glutamate-dopamine interaction and ketamine-induced psychotic symptoms in man. Psychopharmacology (Berl) (2005) 1.14
Nuclear factor erythroid 2-related factor 2 protects against beta amyloid. Mol Cell Neurosci (2008) 1.11
Experience-dependent expression of NPAS4 regulates plasticity in adult visual cortex. J Physiol (2012) 1.10
Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain (2011) 1.10
Encoding of novel picture pairs activates the perirhinal cortex: an fMRI study. Hippocampus (2003) 1.10
Hypothermia in mice tested in Morris water maze. Behav Brain Res (2003) 1.09
Enhanced BDNF signaling is associated with an antidepressant-like behavioral response and changes in brain monoamines. Cell Mol Neurobiol (2005) 1.08
Memantine lowers amyloid-beta peptide levels in neuronal cultures and in APP/PS1 transgenic mice. J Neurosci Res (2010) 1.08
WNT signaling in activated microglia is proinflammatory. Glia (2010) 1.07
Cognition-enhancing and anxiolytic effects of memantine. Neuropharmacology (2008) 1.06
Decreased BDNF signalling in transgenic mice reduces epileptogenesis. Eur J Neurosci (2002) 1.04
Functional interaction of DYX1C1 with estrogen receptors suggests involvement of hormonal pathways in dyslexia. Hum Mol Genet (2009) 1.04
Long-lasting behavioural and molecular alterations induced by early postnatal fluoxetine exposure are restored by chronic fluoxetine treatment in adult mice. Eur Neuropsychopharmacol (2008) 1.03
Tau hyperphosphorylation correlates with reduced methylation of protein phosphatase 2A. Neurobiol Dis (2008) 1.03
Role of alpha-synuclein in synaptic glutamate release. Neurobiol Dis (2007) 1.02
Serotonin triggers a transient epigenetic mechanism that reinstates adult visual cortex plasticity in rats. Eur J Neurosci (2010) 1.02
Cholesterol loss enhances TrkB signaling in hippocampal neurons aging in vitro. Mol Biol Cell (2008) 1.01
Individual differences in neurocognitive aging of the medial temporal lobe. Age (Dordr) (2006) 1.01
Impaired TrkB receptor signaling contributes to memory impairment in APP/PS1 mice. Neurobiol Aging (2011) 1.01
BDNF and TrkB in neuronal differentiation of Fmr1-knockout mouse. Neurobiol Dis (2010) 1.00
Effects of human intravenous immunoglobulin on amyloid pathology and neuroinflammation in a mouse model of Alzheimer's disease. J Neuroinflammation (2012) 0.99
Antidepressant drugs transactivate TrkB neurotrophin receptors in the adult rodent brain independently of BDNF and monoamine transporter blockade. PLoS One (2011) 0.99
Effects of ovariectomy and estrogen treatment on learning and hippocampal neurotransmitters in mice. Horm Behav (2002) 0.97
Physiology, pathology and relatedness of human tissues from gene expression meta-analysis. PLoS One (2008) 0.97
Aberrant differentiation of glutamatergic cells in neocortex of mouse model for fragile X syndrome. Neurobiol Dis (2008) 0.97
Hippocampal A beta 42 levels correlate with spatial memory deficit in APP and PS1 double transgenic mice. Neurobiol Dis (2002) 0.97
BDNF regulates the expression of fragile X mental retardation protein mRNA in the hippocampus. Neurobiol Dis (2002) 0.97
Trustworthiness and metrics in visualizing similarity of gene expression. BMC Bioinformatics (2003) 0.96
Multiple cellular and molecular mechanisms are involved in human Aβ clearance by transplanted adult astrocytes. Glia (2011) 0.96
Spontaneous epileptiform discharges in a mouse model of Alzheimer's disease are suppressed by antiepileptic drugs that block sodium channels. Epilepsy Res (2011) 0.95
Cholinergic system regulation of spatial representation by the hippocampus. Hippocampus (2002) 0.95
Decreased reuptake of dopamine in the dorsal striatum in the absence of α-synuclein. Brain Res (2011) 0.95
The antidepressant-like effects of glutamatergic drugs ketamine and AMPA receptor potentiator LY 451646 are preserved in bdnf⁺/⁻ heterozygous null mice. Neuropharmacology (2011) 0.94
Co-treatment with diazepam prevents the effects of fluoxetine on the proliferation and survival of hippocampal dentate granule cells. Biol Psychiatry (2009) 0.94
Discriminating accuracy of medial temporal lobe volumetry and fMRI in mild cognitive impairment. Hippocampus (2009) 0.94
Estrogen treatment alleviates NMDA-antagonist induced hippocampal LTP blockade and cognitive deficits in ovariectomized mice. Neurobiol Learn Mem (2003) 0.92
Effects of long-term ovariectomy and estrogen treatment on maze learning in aged mice. Exp Gerontol (2004) 0.92
Mobile phone radiation and the developing brain: behavioral and morphological effects in juvenile rats. Radiat Res (2007) 0.92
Brain-derived neurotrophic factor signaling modifies hippocampal gene expression during epileptogenesis in transgenic mice. Eur J Neurosci (2004) 0.91
Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology (2002) 0.91
Lack of collagen XV impairs peripheral nerve maturation and, when combined with laminin-411 deficiency, leads to basement membrane abnormalities and sensorimotor dysfunction. J Neurosci (2010) 0.91
Neurochemical mapping of the human hippocampus reveals perisynaptic matrix around functional synapses in Alzheimer's disease. Acta Neuropathol (2012) 0.90
Amyloid beta deposition is related to decreased glucose transporter-1 levels and hippocampal atrophy in brains of aged APP/PS1 mice. Brain Res (2007) 0.90
Noradrenaline overflow in mouse dentate gyrus following locus coeruleus and natural stimulation: real-time monitoring by in vivo voltammetry. J Neurochem (2005) 0.89
Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology. Neurosci Lett (2008) 0.88
Abnormal compartmentalization of norepinephrine in mouse dentate gyrus in alpha-synuclein knockout and A30P transgenic mice. J Neurochem (2006) 0.88
Mapping of the interaction site between sortilin and the p75 neurotrophin receptor reveals a regulatory role for the sortilin intracellular domain in p75 neurotrophin receptor shedding and apoptosis. J Biol Chem (2012) 0.88
Distinct and overlapping fMRI activation networks for processing of novel identities and locations of objects. Eur J Neurosci (2005) 0.87
The loop diuretic bumetanide blocks posttraumatic p75NTR upregulation and rescues injured neurons. J Neurosci (2012) 0.87
Functional cholinergic damage develops with amyloid accumulation in young adult APPswe/PS1dE9 transgenic mice. Neurobiol Dis (2010) 0.87
Fabrication and testing of polyimide-based microelectrode arrays for cortical mapping of evoked potentials. Biosens Bioelectron (2009) 0.87
From brain to food: analysis of phosphatidylcholins, lyso-phosphatidylcholins and phosphatidylcholin-plasmalogens derivates in Alzheimer's disease human post mortem brains and mice model via mass spectrometry. J Chromatogr A (2011) 0.87
Quantitative determination of acetylcholine in microdialysis samples using liquid chromatography/atmospheric pressure spray ionization mass spectrometry. Rapid Commun Mass Spectrom (2007) 0.87
Overexpression of the full-length neurotrophin receptor trkB regulates the expression of plasticity-related genes in mouse brain. Brain Res Mol Brain Res (2004) 0.87
Neurotrophins and dementia--keeping in touch. Neuron (2006) 0.87
Acetylcholinesterase inhibitors rapidly activate Trk neurotrophin receptors in the mouse hippocampus. Neuropharmacology (2011) 0.86
Spermidine/spermine N1-acetyltransferase overexpression in mice induces hypoactivity and spatial learning impairment. Pharmacol Biochem Behav (2004) 0.86
The aromatase gene CYP19A1: several genetic and functional lines of evidence supporting a role in reading, speech and language. Behav Genet (2012) 0.86
Aging and alpha-synuclein affect synaptic plasticity in the dentate gyrus. J Neural Transm (Vienna) (2008) 0.86
Contribution of genetic and dietary insulin resistance to Alzheimer phenotype in APP/PS1 transgenic mice. J Cell Mol Med (2012) 0.86
Effects of antidepressant drug imipramine on gene expression in rat prefrontal cortex. Neurochem Res (2004) 0.85
Uncoupling of M1 muscarinic receptor/G-protein interaction by amyloid β(1-42). Neuropharmacology (2012) 0.85
Methylphenidate modifies overflow and presynaptic compartmentalization of dopamine via an α-synuclein-dependent mechanism. J Pharmacol Exp Ther (2012) 0.85
Brain reward in the absence of alpha-synuclein. Neuroreport (2006) 0.85
Alteration of cortical EEG in mice carrying mutated human APP transgene. Brain Res (2002) 0.85